113 related articles for article (PubMed ID: 187278)
1. Vaccination against EB virus.
Br Med J; 1976 Dec; 2(6050):1467-8. PubMed ID: 187278
[No Abstract] [Full Text] [Related]
2. Epstein-Barr virus. Is it timely to discuss a vaccine?
Biomedicine; 1978; 28(1):15-7. PubMed ID: 208671
[No Abstract] [Full Text] [Related]
3. Implications of a vaccine for the prevention of Epstein-Barr virus infection: ethical and logistic considerations.
Epstein MA
Cancer Res; 1976 Feb; 36(2 pt 2):711-4. PubMed ID: 175931
[TBL] [Abstract][Full Text] [Related]
4. Prevention of Epstein-Barr (EB) virus-induced lymphoma in cottontop tamarins by vaccination with the EB virus envelope glycoprotein gp340 incorporated into immune-stimulating complexes.
Morgan AJ; Finerty S; Lovgren K; Scullion FT; Morein B
J Gen Virol; 1988 Aug; 69 ( Pt 8)():2093-6. PubMed ID: 2841417
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus--is it time to develop a vaccine program?
Epstein MA
J Natl Cancer Inst; 1976 Apr; 56(4):697-700. PubMed ID: 176406
[No Abstract] [Full Text] [Related]
6. Vaccination against Epstein-Barr virus: current progress and future strategies.
Epstein MA
Lancet; 1986 Jun; 1(8495):1425-7. PubMed ID: 2872525
[TBL] [Abstract][Full Text] [Related]
7. Clinical consequences of Epstein-Barr virus infection and possible control by an anti-viral vaccine.
Epstein MA; Morgan AJ
Clin Exp Immunol; 1983 Aug; 53(2):257-71. PubMed ID: 6309441
[No Abstract] [Full Text] [Related]
8. [Viruses and human cancers: fundamental aspects and hopes of prevention].
de Thé G
C R Seances Soc Biol Fil; 1986; 180(3):249-61. PubMed ID: 3022897
[No Abstract] [Full Text] [Related]
9. The 1986 Walter Hubert lecture. Recent studies on a vaccine to prevent EB virus-associated cancers.
Epstein MA
Br J Cancer; 1986 Jul; 54(1):1-5. PubMed ID: 3015179
[TBL] [Abstract][Full Text] [Related]
10. Approaches to immunological control of virus-associated tumors in man: introductory remarks.
Levine PH
Cancer Res; 1976 Feb; 36(2 pt 2):565-9. PubMed ID: 175916
[No Abstract] [Full Text] [Related]
11. Immunologic markers for Epstein-Barr virus in the control of nasopharyngeal carcinoma and Burkitt lymphoma.
Levine PH
Cancer Detect Prev Suppl; 1987; 1():217-23. PubMed ID: 2826001
[TBL] [Abstract][Full Text] [Related]
12. The Leeuwenhoek lecture, 1983. A prototype vaccine to prevent Epstein-Barr virus-associated tumours.
Epstein MA
Proc R Soc Lond B Biol Sci; 1984 Mar; 221(1222):1-20. PubMed ID: 6144103
[TBL] [Abstract][Full Text] [Related]
13. Viral infections and cancer in the tropics.
Epstein MA
Trop Geogr Med; 1988 Jul; 40(3):S52-60. PubMed ID: 3055566
[No Abstract] [Full Text] [Related]
14. Cancer vaccine goes on trial.
Practitioner; 1986 Apr; 230(1414):307-8. PubMed ID: 3090538
[No Abstract] [Full Text] [Related]
15. A prototype vaccine to prevent Epstein-Barr virus-associated cancers.
Epstein M
Chemioterapia; 1987 Jun; 6(2 Suppl):655-8. PubMed ID: 2855615
[No Abstract] [Full Text] [Related]
16. Issues related to development of Epstein-Barr virus vaccines.
Spring SB; Hascall G; Gruber J
J Natl Cancer Inst; 1996 Oct; 88(20):1436-41. PubMed ID: 8841018
[No Abstract] [Full Text] [Related]
17. Epstein-Barr virus behavior in different populations and implications for control of Epstein-Barr virus-associated tumors.
de-Thé G
Cancer Res; 1976 Feb; 36(2 pt 2):692-5. PubMed ID: 1253156
[TBL] [Abstract][Full Text] [Related]
18. Recombinant vaccinia virus expressing Epstein-Barr virus glycoprotein gp340 protects cottontop tamarins against EB virus-induced malignant lymphomas.
Morgan AJ; Mackett M; Finerty S; Arrand JR; Scullion FT; Epstein MA
J Med Virol; 1988 Jun; 25(2):189-95. PubMed ID: 2839612
[TBL] [Abstract][Full Text] [Related]
19. What we could do with an EBV vaccine.
Lancet; 1981 Apr; 1(8223):759-61. PubMed ID: 6110958
[No Abstract] [Full Text] [Related]
20. [Epstein-Barr virus and human cancer].
Quattrocchi C; Signorile PG
Recenti Prog Med; 1980 May; 68(5):504-42. PubMed ID: 6256832
[No Abstract] [Full Text] [Related]
[Next] [New Search]
